Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: About 20% of patients (pts) with neuroendocrine tumors (NET) suffer from carcinoid syndrome (CS), mainly from ileum and lung NET. Pts with CS experience symptoms such as diarrhea, flushes and cardiac complications. The diarrhea occurs in almost all pts with CS and can be truly debilitating. Therefore, on top of the tumor, the burden of the symptoms further impairs quality of life and is associated with additional costs related to symptom management and pts follow-up.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Walter T
Authors: Walter T, Lapeyre Mestre M, Gueguen D, Bouille C, Laborey M,
Keywords: Carcinoid syndrome, resources, health economics,
Introduction: A new syringe (NS) for the delivery of lanreotide autogel was approved in Oct 2018 in France. The NS includes updated features (larger flanges, more robust plunger) intended to ease the injection.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: Walter T, Eskenazi M, Rama N, Gueguen D, Mir O,
Keywords: neuroendocrine tumors, lanreotide, nursing, patient-reported outcomes,
Introduction: Patients (pts) with NET experience consequences of disease progression and treatments; their preferences can influence the choice and success of therapeutic strategies.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author: SARABI M
Authors: Sarabi M, Gueguen D, Walter T, Hentic O, Baudin E,
Keywords: Patient Report Outcomes, Neuroendocrine Tumor, Quality of life,
Introduction: Information provided to patients about burden and treatment of neuroendocrine tumors (NETs) may ease treatment adherence, outpatient monitoring, and improve quality of life (QoL), but can also cause anxiety. Data on how to individually adapt materials are insufficient and mainly derived from clinical trials.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author:
Keywords: patients perception of information, QoL, lanreotide,